Amedisys (AMED) Tops Q2 EPS by 28c
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Equity in earnings from unconsolidated joint ventures: 3.24M
Today's EPS Names:
UBAB, LOAN, FITB, More
Financial Fact:
Equity in earnings from unconsolidated joint ventures: 3.24M
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q2 EPS of $1.37, $0.28 better than the analyst estimate of $1.09. Revenue for the quarter came in at $552.97 million versus the consensus estimate of $568.18 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
- DB cautious on cruise stocks as fundamentals “not as clear as bulls believe”
- Autoliv (ALV) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
